1. Runt-Related Transcription Factor 2 Induction During Differentiation of Wharton's Jelly Mesenchymal Stem Cells to Osteoblasts Is Regulated by Jumonji AT-Rich Interactive Domain 1B Histone Demethylase
   Francisco Bustos et al, 2017, Stem Cells CrossRef
2. KDM5B decommissions the H3K4 methylation landscape of self-renewal genes during trophoblast stem cell differentiation
   Jian Xu et al, 2018, Biology Open CrossRef
3. Impaired removal of H3K4 methylation affects cell fate determination and gene transcription
   Yvonne C. Lussi et al, 2016, Development CrossRef
4. Lysine demethylase 5B (KDM5B): A potential anti-cancer drug target
   Yi-Chao Zheng et al, 2018, European Journal of Medicinal Chemistry CrossRef
5. KDM5 lysine demethylases are involved in maintenance of 3′UTR length
   Lauren P. Blair et al, 2016, Sci. Adv. CrossRef
6. The Set1 complex is dimeric and acts with Jhd2 demethylation to convey symmetrical H3K4 trimethylation
   Rupam Choudhury et al, 2019, Genes Dev. CrossRef
7. Phosphorylation of the histone demethylase KDM5B and regulation of the phenotype of triple negative breast cancer
   I-Ju Yeh et al, 2019, Sci Rep CrossRef
8. The histone demethylase KDM5 controls developmental timing in Drosophila by promoting prothoracic gland endocycles
   Coralie Drelon et al, 2019, Development CrossRef
9. Targeting JARID1B’s demethylase activity blocks a subset of its functions in oral cancer
   Nicole D. Facompre et al, 2018, Oncotarget CrossRef
10. Histone demethylase lysine demethylase 5B in development and cancer
    Mengjiao Han et al, 2017, Oncotarget CrossRef
11. null
    Fátima L. Monteiro et al, 2020 CrossRef
12. Histone Demethylase KDM5B as a Therapeutic Target for Cancer Therapy
    Anmi Jose et al, 2020, Cancers CrossRef
13. Roles of HIF and 2-Oxoglutarate-Dependent Dioxygenases in Controlling Gene Expression in Hypoxia
    Julianty Frost et al, 2021, Cancers CrossRef
14. Mechanisms of Oocyte Maturation and Related Epigenetic Regulation
    Meina He et al, 2021, Front. Cell Dev. Biol. CrossRef
15. Expression and prognostic values of ARID family members in breast cancer
    Jinfeng Zhang et al, 2021, Aging CrossRef
16. Lysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers
    Gaya Punnia-Moorthy et al, 2021, Front. Genet. CrossRef
17. Epigenetic Factors as Etiological Agents, Diagnostic Markers, and Therapeutic Targets for Luminal Breast Cancer
    Nguyen Xuan Thang et al, 2022, Biomedicines CrossRef
18. Diverse Functions of KDM5 in Cancer: Transcriptional Repressor or Activator?
    Yasuyo Ohguchi et al, 2022, Cancers CrossRef
19. Functions and Interactions of Mammalian KDM5 Demethylases
    Egor Pavlenko et al, 2022, Front. Genet. CrossRef
20. null
    Nihal Terzi Cizmecioglu, 2024 CrossRef
21. Mechanistic QSAR modeling derived virtual screening, drug repurposing, ADMET and in - vitro evaluation to identify anticancer lead as lysine-specific demethylase 5a inhibitor
    Rahul D. Jawarkar et al, 2024, Journal of Biomolecular Structure and Dynamics CrossRef
22. H4K20me3, H3K4me2 and H3K9me2 mediate the effect of ER on prognosis in breast cancer
    Cheng-Kun Xiao et al, 2024, Epigenetics CrossRef
23. The Intellectual Disability Risk GeneKdm5bRegulates Long-Term Memory Consolidation in the Hippocampus
    Leticia Pérez-Sisqués et al, 2024, J. Neurosci. CrossRef
24. Epigenetic Regulation of Angiogenesis by JARID1B-Induced Repression of HOXA5
    Christian Fork et al, 2015, ATVB CrossRef